维普期刊资源整合服务平台（V6.5）

267篇 您的检索式：作者名="Anderson KC"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	Computer assisted navigation in total knee arthroplasty: comparison with conventional methods 显示文摘	Anderson KC Buehler KC Markel DC	2005	J Arthroplasty2005，20，：	1
2	Introduction:the evolving role of bisphosphonate therapy in multiple myeloma显示文摘	Raje N Anderson KC	2000	Blood2000，96，2：	1
3	Transfusion-associated graftversus-host disease显示文摘	Anderson KC Weinstein HJ	1990	New Engl J Med1990，323，19：	1
4	Transfusion - related sepsis after prolonged platelet storage显示文摘	Anderson KC Lew MA Gorgone BC	1986	Am J Med1986，，81：	1
5	Bone marrow micro- environment and the identification of new targets for myeloma therapy显示文摘	Podar K Chanhan D Anderson KC	2009	Leukemia2009，23，1：	1
6	Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma:distinct clinicopathologic entities显示文摘	Anderson WF Chu KC Chang S		0，，12：	1
7	Thalidomide and immunomodulatory as cancer therapy显示文摘	Raje N Anderson KC	2002	Curr Opin Oncol2002，14，6：	1
8	NCCN clinical practice guidelines in oncology : multiple myeloma 显示文摘	Anderson KC Alsina M Bensinger W	2009	J Natl Compr Canc Netw2009，7，9：	1
9	Bortezomib (PS-341) :a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers 显示文摘	Richardson PG Hideshima T Anderson KC	2003	Cancer Control2003，10，5：	1
10	Arsenic trioxide in multiple myeloma: raft onale and future directions 显示文摘	Anderson KC Boise LH Louie R	2002	Cancer J2002，8，4：	1
11	The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function 显示文摘	Eveson G Lassete KC Anderson KE	2000	Br j Clin Pharmacol2000，，：	1
12	Peripheral neuropa- thy in multiple mycloma patients receiving lenalidomide, borte- zomib, and dexamethasone (RVD) therapy 显示文摘	Voorhees PM Laubach J Anderson KC	2013	Blood2013，121，：	1
13	Molecular mechanisms of novel therapeutic approaches for multiple myeloma显示文摘	Hideshima T Anderson KC	2002	Nat Rev Cancer2002，2，12：	1
14	Novel therapies in myeloma显示文摘	Hayden PJ Mitsiades CS Anderson KC	2007	Curr Opin Hematol2007，14，6：	1
15	Targeted therapy for multiple myeloma显示文摘	Anderson KC	2001	SeminHematol2001，38，3：	1
16	Molecular mechanisms of novel therapeutic approachesformultiple myeloma显示文摘	Hideshima T Anderson KC	2002	Nat Rev Cancer2002，2，12：	1
17	The pathophysiologic role of VEGF in hematologic malignancies:therapeutic implications显示文摘	Podar K Anderson KC	2005	Blood2005，105，：	1
18	Bone marrow microenvironment and the identification of new targets for myeloma therapy显示文摘	Podar K Chauhan D Anderson KC	2009	Leukemia2009，23，：	1
19	Clinical practice guidelines of the American Society of Clinical Oncology显示文摘	Schiffer CA Anderson KC Bennett C	2001	J Clin Oneol2001，，19：	1
20	The pathophysiologic role of VEGF in hematologic malignancies:therapeutic implications显示文摘	Anderson KC	2005	Blood2005，105，4：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示